Breaking News Instant updates and real-time market news.

2019-11-04 17:06:36 STE Steris $140.42 -1.745 (-1.23%) 17:06 11/04/19 11/04 17:06 11/04/19 17:06	Steris sees FY20 EPS $5.50 - $5.65, consensus $5.47 Based on current performance and expectations for the full fiscal year, the Company is updating its prior outlook for revenue and adjusted earnings per diluted share. Constant currency organic revenue growth is now expected to be in the range of 7.5-8.5%, compared with 6-7% previously. The increase in constant currency organic revenue growth is due to outperformance of the underlying business as well as approximately one percentage point benefit from a number of tuck-in acquisitions completed in the first half of the year. Reflecting September 30, 2019 forward rates, the Company now expects that currency movements will negatively impact as reported revenue by approximately $25 million in fiscal 2020. Adjusted earnings per diluted share are now anticipated to be in the range of $5.50 - $5.65, compared with $5.38 - $5.53 previously. Consensus for FY20 revenue is $2.96B.	05 Nov 13 Nov 03 Dec
STE Steris $140.42 -1.745 (-1.23%) 11/13/18 KEYB 11/13/18 NO CHANGE Target $132 KEYB Overweight STERIS price target raised to $132 from $120 at KeyBanc KeyBanc analyst Matthew Mishan raised his price target for STERIS to $132 from $120 post Q2. Moving forward, the analyst continues to believe that there are drivers to sustain long-term organic revenue growth at over 5%, it seems capable of offsetting various cost headwinds and there is opportunity for steady operating margin expansion, and eventually, there could be upside to estimates from EPS accretive M&A. Mishan reiterates an Overweight rating on the shares. 05/15/19 SPHN 05/15/19 NO CHANGE Target $150 SPHN Overweight STERIS price target raised to $150 from $135 at Stephens Stephens analyst Chris Cooley raised his price target on STERIS shares to $150 from $135 after the company reported Q4 results that topped consensus, noting that all four of the its business segments had better than expected revenue growth and increased operating margins. Cooley, who said he is confident STERIS can either meet or exceed its FY20 guidance, keeps an Overweight rating on the shares, which he continues to view as a "core holding." 07/09/19 KEYB 07/09/19 DOWNGRADE KEYB Sector Weight STERIS downgraded to Sector Weight from Overweight at KeyBanc 07/10/19 KEYB 07/10/19 DOWNGRADE KEYB Sector Weight Steris downgraded to Sector Weight on valuation at KeyBanc KeyBanc analyst Matthew Mishan last night downgraded Steris to Sector Weight from Overweight with the shares above his previous price target of $138. The stock, after rallying 43% year-to-date, could be reaching its "vertical limit," Mishan tells investors in a research note. With that said, the analyst remains confident in a "sustained runway for organic growth" for Steris.

2019-11-04 17:06:36

STE

Steris

$140.42: -1.745 (-1.23%)

17:06

11/04/19

11/04

17:06

11/04/19

17:06

Steris sees FY20 EPS $5.50 - $5.65, consensus $5.47

Based on current performance and expectations for the full fiscal year, the Company is updating its prior outlook for revenue and adjusted earnings per diluted share. Constant currency organic revenue growth is now expected to be in the range of 7.5-8.5%, compared with 6-7% previously. The increase in constant currency organic revenue growth is due to outperformance of the underlying business as well as approximately one percentage point benefit from a number of tuck-in acquisitions completed in the first half of the year. Reflecting September 30, 2019 forward rates, the Company now expects that currency movements will negatively impact as reported revenue by approximately $25 million in fiscal 2020. Adjusted earnings per diluted share are now anticipated to be in the range of $5.50 - $5.65, compared with $5.38 - $5.53 previously. Consensus for FY20 revenue is $2.96B.

05
Nov
13
Nov
03
Dec

STE Steris

$140.42: -1.745 (-1.23%)

11/13/18: KEYB

05/15/19: SPHN

07/09/19: KEYB

07/10/19: KEYB

TODAY'S FREE FLY STORIES

UPS UPS $116.87 -0.67 (-0.57%) 10:15 12/09/19 12/09 10:15 12/09/19 10:15 Hot Stocks	UPS reports expansion of UPS Worldwide Express, Express Plus across 40 countries » UPS announced an… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CNC Centene $60.30 -0.69 (-1.13%) 10:15 12/09/19 12/09 10:15 12/09/19 10:15 Options	Centene put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
CNST Constellation Pharmaceuticals $47.50 3.4 (7.71%) 10:14 12/09/19 12/09 10:14 12/09/19 10:14 Hot Stocks	Breaking Hot Stocks news story on Constellation Pharmaceuticals » Constellation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
ACHN Achillion $6.19 0.02 (0.32%) 10:14 12/09/19 12/09 10:14 12/09/19 10:14 Hot Stocks	Achillion reports 'positive' data from Phase 2 danicopan, eculizumab study » Achillion Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	19 Dec
ATRA Atara Biotherapeutics $14.24 0.25 (1.79%) 10:12 12/09/19 12/09 10:12 12/09/19 10:12 Hot Stocks	Atara reports updated long-term clinical results from Tab-cel EBV+ PTLD study » Atara Biotherapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

GLOB Globant $102.78 -0.525 (-0.51%) 10:12 12/09/19 12/09 10:12 12/09/19 10:12 Conference/Events	Globant management to meet with JPMorgan » Meeting to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 11 Dec 16 Jan
CNST Constellation Pharmaceuticals $47.50 3.4 (7.71%) 10:12 12/09/19 12/09 10:12 12/09/19 10:12 Hot Stocks	Constellation Pharmaceuticals provides update on MANIFEST clinical trial » Constellation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
DTIL Precision BioSciences $18.00 -1.66 (-8.44%) 10:11 12/09/19 12/09 10:11 12/09/19 10:11 Hot Stocks	Breaking Hot Stocks news story on Precision BioSciences » Precision BioSciences Inc… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
MTEM Molecular Templates $12.23 (0.00%) 10:10 12/09/19 12/09 10:10 12/09/19 10:10 Hot Stocks	Molecular Templates announces presentations of two posters at ASH » Molecular Templates… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CAR Avis Budget $31.72 0.545 (1.75%) 10:10 12/09/19 12/09 10:10 12/09/19 10:10 Conference/Events	Avis Budget management to meet with JPMorgan » Meetings to be held in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 10 Dec

XNCR Xencor $41.27 0.25 (0.61%) 10:08 12/09/19 12/09 10:08 12/09/19 10:08 Hot Stocks	Xencor presents Initial Data from Phase 1 Study of XmAb 13676 » Xencor announced initial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
SGEN Seattle Genetics $117.12 -0.4 (-0.34%) , TAK Takeda Pharmaceutical $20.12 -0.15 (-0.74%) 10:08 12/09/19 12/09 10:08 12/09/19 10:08 Hot Stocks	Seattle Genetics, Takeda announce additional analyses of Adcetris » Seattle Genetics (SGEN)… SGEN Seattle Genetics $117.12 -0.4 (-0.34%) TAK Takeda Pharmaceutical $20.12 -0.15 (-0.74%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Mar
DTIL Precision BioSciences $19.88 0.22 (1.12%) 10:06 12/09/19 12/09 10:06 12/09/19 10:06 Hot Stocks	Breaking Hot Stocks news story on Precision BioSciences » Precision BioSciences Inc… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
ARMK Aramark $42.70 -0.32 (-0.74%) 10:06 12/09/19 12/09 10:06 12/09/19 10:06 Conference/Events	Aramark management to meet with JPMorgan » Meeting to be held in New… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec
INTC Intel $56.80 (0.00%) 10:04 12/09/19 12/09 10:04 12/09/19 10:04 Hot Stocks	Intel reveals what it believes to be a first-of-its-kind cryogenic control chip » Intel Labs unveiled what… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 23 Jan

CNST Constellation Pharmaceuticals $48.50 4.4 (9.98%) 10:04 12/09/19 12/09 10:04 12/09/19 10:04 Hot Stocks	Breaking Hot Stocks news story on Constellation Pharmaceuticals » Constellation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
10:01 12/09/19 12/09 10:01 12/09/19 10:01 Conference/Events	JPMorgan media analyst to hold an analyst/industry conference call » Media Analyst Quadrani… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
CHWY Chewy $24.75 -0.18 (-0.72%) 10:00 12/09/19 12/09 10:00 12/09/19 10:00 Options	Notable put buying in Chewy ahead of earnings » Notable put buying in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 09 Dec
SSI Stage Stores $6.30 0.695 (12.40%) 10:00 12/09/19 12/09 10:00 12/09/19 10:00 Hot Stocks	Stage Stores rises 11.5% » Stage Stores is up 11.5%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
PCG PG&E $11.16 1.51 (15.65%) 10:00 12/09/19 12/09 10:00 12/09/19 10:00 Hot Stocks	PG&E rises 15.8% » PG&E is up 15.8%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Jan

DGAZ VelocityShares 3x Inv Natural Gas ETN $182.40 26.61 (17.08%) 10:00 12/09/19 12/09 10:00 12/09/19 10:00 Hot Stocks	VelocityShares 3x Inv Natural Gas ETN rises 17.0% » VelocityShares 3x Inv… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
09:58 12/09/19 12/09 09:58 12/09/19 09:58 Conference/Events	JPMorgan oil services/equip analyst to hold an analyst/industry conference call » Oil Services &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
PCG PG&E $11.30 1.65 (17.10%) , SIG Signet Jewelers $21.05 0.48 (2.33%) … 09:55 12/09/19 12/09 09:55 12/09/19 09:55 Options	Early notable gainers among liquid option names on December 9th » Notable gainers among… PCG PG&E $11.30 1.65 (17.10%) SIG Signet Jewelers $21.05 0.48 (2.33%) SWKS Skyworks $104.20 2.8 (2.76%) FCX Freeport McMoRan $11.97 0.33 (2.84%) FTV Fortive $75.51 2.65 (3.64%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	09 Dec 07 Jan
09:55 12/09/19 12/09 09:55 12/09/19 09:55 Conference/Events	JPMorgan homebuilding analyst to hold an analyst/industry conference call » Homebuilding &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
09:55 12/09/19 12/09 09:55 12/09/19 09:55 Conference/Events	JPMorgan business services analyst to hold analyst/industry conference call » Business &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

DSS
Today at 10:30

Document Security Systems, Inc. Firm Sponsored Meetings

NY
Today at 10:30

Business & Information Services Industry Meetings
ATEA
Today at 11:00

ASTEA INTERNATIONAL INC. Firm Sponsored Meetings

240 Gibraltar Road, Horsham, PA
BKJ
Today at 11:00

Bancorp Of New Jersey, Inc. Firm Sponsored Meetings

2117 Route 4 East, Fort Lee, NJ
Today at 11:00

Economics & Strategy--Mexico Industry Meetings
Today at 11:00

Alternative Energy & Environmental Services Industry Meetings
Today at 11:00

Biotechnology Industry Meetings
Today at 11:30

3-Month Bill Auction Government Event
Today at 11:30

6-Month Bill Auction Government Event
SPT
Today at 12:00

Sprout Social - SPT Syndicate Roadshows

San Francisco, CA

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs $48.95-50.89 2.2M Shares AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton $15.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS $22.00-25.00 72.511M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair $16.00-18.00 8.824M Shares EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number $12.50-14.50 3.2M Shares MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital $19.70 11M Shares
Thurs	OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc $12.00-14.00 36M Shares SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel $16.00-18.00 8.824M Shares
Fri	No deals

View All Syndicate Announcements »

Steris sees FY20 EPS $5.50 - $5.65, consensus $5.47

TODAY'S FREE FLY STORIES

Get Full Fly Access